Volume 2.45 | Nov 15

Pancreatic Cell News 2.45, November 15, 2011
     In this issue: Publications | Science News | Industry News | Policy News | Events | Jobs 
Cell Therapy News on Facebook  Pancreatic Cell News on Twitter
Preventing Pancreatic Cell Death in Type 1 Diabetes
Diabetes researchers have developed a method to detect and measure the destruction of beta cells that occurs in the pancreas by measuring DNA expression in the blood. [Press release from Yale University discussing online prepublication in the Proceedings of the National Academy of Sciences, USA] Press Release | Abstract

Webinar: Affordable, Defined hPSC Culture? Watch the video now.
PUBLICATIONS (Ranked by Impact Factor of the Journal)


Chemical Screen Identifies FDA-Approved Drugs and Target Pathways that Induce Precocious Pancreatic Endocrine Differentiation
Scientists conducted a chemical screen to identify compounds that would induce the differentiation of insulin-producing β-cells in vivo. [Proc Natl Acad Sci USA] Abstract

Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-Islet Allo- and Autoimmune Responses
Herein, researchers provide an extensive study of the effect of B-cell depletion in murine models of islet transplantation. [Diabetes] Abstract

The Functional and Molecular Characterization of Human Embryonic Stem Cell-Derived Insulin-Positive Cells Compared with Adult Pancreatic Beta Cells
Using a novel directed differentiation protocol, researchers recently generated up to 25% insulin-producing cells from human embryonic stem cells (insulin+ cells). Insulin+ cells were examined for key features of adult beta cells using microarray, quantitative PCR, secretion assays, imaging and electrophysiology. [Diabetologia] Abstract

Reduction of Both Beta Cell Death and Alpha Cell Proliferation by Dipeptidyl Peptidase-4 Inhibition in a Streptozotocin-Induced Model of Diabetes in Mice
Researchers assessed whether dipeptidyl peptidase-4 (DPP-4) inhibition suppresses the progression to hyperglycaemia in a low-dose streptozotocin-induced diabetic mouse model, and then investigated how DPP-4 inhibition affects islet function and morphology. [Diabetologia] Abstract

Autophagy Deficiency in Beta Cells Leads to Compromised Unfolded Protein Response and Progression from Obesity to Diabetes in Mice
Scientists investigated the role of autophagy in unfolded protein response of pancreatic beta cells and the susceptibility of autophagy-deficient beta cells to the endoplasmic reticulum stress that is implicated in the development of diabetes. [Diabetologia] Abstract


Restricted Heterochromatin Formation Links NFATc2 Repressor Activity with Growth Promotion in Pancreatic Cancer
Here, researchers demonstrate a novel pathway involving the oncogenic transcription factor NFATc2 targeting p15INK4b mediated failsafe mechanism to promote pancreatic cancer tumor growth. [Gastroenterology] Abstract

Imaging Guided Trials of the Angiogenesis Inhibitor Sunitinib in Mouse Models Predict Efficacy in Pancreatic Neuroendocrine but Not Ductal Carcinoma
Researchers evaluated sunitinib, an angiogenesis inhibitor that targets VEGF and PDGF receptor signaling, in two genetically engineered mouse models of pancreatic cancer. [Proc Natl Acad Sci USA] Abstract

Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
In this study, researchers provide evidence that MLN4924 can be used as an effective radiosensitizer in pancreatic cancer. [Cancer Res] Abstract

Proteome of Formalin-Fixed Paraffin-Embedded Pancreatic Ductal Adenocarcinoma and Lymph Node Metastases
To better understand pancreatic ductal adenocarcinoma metastatic spread and identify novel therapeutic targets, investigators analyzed the proteome of primary tumors and matched lymph node metastases. [J Pathol] Abstract

Synergistic Antitumor Effect of Adenovirus-Mediated hING4 Gene Therapy and 125I Radiation Therapy on Pancreatic Cancer
In this study, scientists demonstrated that either inhibitor of growth 4 (ING4) or 125I radiotherapy treatment could induce Panc-1 pancreatic cancer cell growth suppression and apoptosis in vitro. [Cancer Lett] Abstract

Listen Now: New Podcast on ALDH in Breast Cancer Treatment Response

Direct Injection Vaccine Treatment for Pancreas Cancer Associated with Stable Disease
A series of vaccine injections given directly into a pancreatic cancer tumor was shown to be associated with stable disease in patients who are not candidates for surgery. [Press release from The Cancer Institute of New Jersey discussing research presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, San Francisco] Press Release

Mesoblast Reports Positive Results Using Intravenously Injected Adult Stem Cells for Type II Diabetes
Mesoblast Limited announced that a single intravenous injection of its proprietary adult stem cells resulted in significant lowering of blood sugar levels for up to eight weeks in a controlled, randomized preclinical trial in non-human primates with Type II diabetes. [Press release from Mesoblast Limited discussing research presented at the Credit Suisse Healthcare Conference, Phoenix] Press Release

Scripps Research Scientist Receives $1 Million Research Grant from Novo Nordisk
Andrew Butler, an associate professor in The Scripps Research Institute’s Department of Metabolism and Aging, has been awarded $1 million in funding over the next two years to further his research into a novel protein with the potential to improve the understanding and future treatment of diabetes. [The Scripps Research Institute] Press Release

$100 Million Gift Establishes Belfer Research Building at Weill Cornell Medical College
In the presence of U.S. Congresswoman Carolyn B. Maloney, Weill Cornell Medical College dedicated the Belfer Research Building, a state-of-the-art facility that will more than double the Medical College’s existing research space and position Weill Cornell at the vanguard of new medical research and discoveries. [Weill Cornell Medical College] Press Release


National Institutes of Health (United States)

Food and Drug Administration (United States)
Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

National Health Service (United Kingdom)

Therapeutic Goods Administration (Australia)

NEW 7th Annual Stem Cell Summit
February 21, 2012
New York, United States

Visit our events page to see a complete list of events in the pancreatic cell community.

Lab Technologist – Tissue Culture (STEMCELL Technologies)

Research and Development Technologist, hPSC Media (STEMCELL Technologies) 

Lab Technologist – Pluripotent Stem Cells (STEMCELL Technologies)

Scientist – Pluripotent Stem Cells (STEMCELL Technologies)

Scientific Marketing Communications Specialist (STEMCELL Technologies)

Postdoctoral Fellow – Islet Cell Electrophysiology (Vanderbilt University)    

Professor of Metabolism and Diabetes (Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Jobs are categorized regionally:
United States, Canada, Europe, Asia Pacific

Visit here to post your career opportunities.

Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Pancreatic Cell News: Archives | Events | Contact Us